Skip to content
Screenshot 2022-07-18 112018

Returning 2023

REGISTER INTEREST
  • Home
  • About
    • About Event
  • 2022 Program
    • 2022 Full Event Guide
    • 2022 Speakers
  • 2022 Partners
    • 2022 Partners
    • Partnership Opportunities
  • Get Involved
    • Register Interest
    • Contact Us

OD260 Inc

By digitalsystems | 5th August 2019

OD260 Inc is your ideal partner for the pre-clinical development of oncolytic adenovirus vectors. With more than 20 years experience in the field, we will help you with the design and construction of your vector and the generation of validated virus stocks for in vitro and animal studies (up to 10¹⁵ VP). QC tests include confirmation of virus identity (genome sequencing), physical and infectious titer (VP/IU), genetic and thermal stability, and verification of transgene expression.

OUR CONTACT DETAILS

T: +1 617 455 4188
E: info@hansonwade.com

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.